290 related articles for article (PubMed ID: 24561670)
1. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells.
Reiter C; Capcı Karagöz A; Fröhlich T; Klein V; Zeino M; Viertel K; Held J; Mordmüller B; Emirdağ Öztürk S; Anıl H; Efferth T; Tsogoeva SB
Eur J Med Chem; 2014 Mar; 75():403-12. PubMed ID: 24561670
[TBL] [Abstract][Full Text] [Related]
2. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids.
Reiter C; Fröhlich T; Zeino M; Marschall M; Bahsi H; Leidenberger M; Friedrich O; Kappes B; Hampel F; Efferth T; Tsogoeva SB
Eur J Med Chem; 2015 Jun; 97():164-72. PubMed ID: 25965779
[TBL] [Abstract][Full Text] [Related]
3. Trioxaferroquines as new hybrid antimalarial drugs.
Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
[TBL] [Abstract][Full Text] [Related]
4. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
Rudrapal M; Chetia D
Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new betulinic acid/betulin-derived dimers and hybrids with potent antimalarial and antiviral activities.
Karagöz AÇ; Leidenberger M; Hahn F; Hampel F; Friedrich O; Marschall M; Kappes B; Tsogoeva SB
Bioorg Med Chem; 2019 Jan; 27(1):110-115. PubMed ID: 30503412
[TBL] [Abstract][Full Text] [Related]
6. Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin.
Çapcı Karagöz A; Reiter C; Seo EJ; Gruber L; Hahn F; Leidenberger M; Klein V; Hampel F; Friedrich O; Marschall M; Kappes B; Efferth T; Tsogoeva SB
Bioorg Med Chem; 2018 Jul; 26(12):3610-3618. PubMed ID: 29887512
[TBL] [Abstract][Full Text] [Related]
7. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.
Rudrapal M; Chetia D; Singh V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents.
Tiwari MK; Coghi P; Agrawal P; Shyamlal BRK; Jun Yang L; Yadav L; Peng Y; Sharma R; Yadav DK; Sahal D; Kam Wai Wong V; Chaudhary S
ChemMedChem; 2020 Jul; 15(13):1216-1228. PubMed ID: 32392362
[TBL] [Abstract][Full Text] [Related]
9. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds.
Gruber L; Abdelfatah S; Fröhlich T; Reiter C; Klein V; Tsogoeva SB; Efferth T
Molecules; 2018 Apr; 23(4):. PubMed ID: 29642419
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells.
Letis AS; Seo EJ; Nikolaropoulos SS; Efferth T; Giannis A; Fousteris MA
Bioorg Med Chem; 2017 Jul; 25(13):3357-3367. PubMed ID: 28456567
[TBL] [Abstract][Full Text] [Related]
12. New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells.
Reiter C; Herrmann A; Çapci A; Efferth T; Tsogoeva SB
Bioorg Med Chem; 2012 Sep; 20(18):5637-41. PubMed ID: 22884578
[TBL] [Abstract][Full Text] [Related]
13. Ferrocene-pyrimidine conjugates: Synthesis, electrochemistry, physicochemical properties and antiplasmodial activities.
Chopra R; de Kock C; Smith P; Chibale K; Singh K
Eur J Med Chem; 2015 Jul; 100():1-9. PubMed ID: 26057222
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
[TBL] [Abstract][Full Text] [Related]
15. 4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials.
Nqoro X; Aderibigbe BA
Recent Pat Antiinfect Drug Discov; 2020; 15(2):157-172. PubMed ID: 32753021
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds.
Rojas Ruiz FA; García-Sánchez RN; Estupiñan SV; Gómez-Barrio A; Torres Amado DF; Pérez-Solórzano BM; Nogal-Ruiz JJ; Martínez-Fernández AR; Kouznetsov VV
Bioorg Med Chem; 2011 Aug; 19(15):4562-73. PubMed ID: 21723734
[TBL] [Abstract][Full Text] [Related]
18. Coumarin-trioxane hybrids: synthesis and evaluation as a new class of antimalarial scaffolds.
Sashidhara KV; Kumar A; Dodda RP; Krishna NN; Agarwal P; Srivastava K; Puri SK
Bioorg Med Chem Lett; 2012 Jun; 22(12):3926-30. PubMed ID: 22607674
[TBL] [Abstract][Full Text] [Related]
19. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
Peter S; Aderibigbe BA
Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
[TBL] [Abstract][Full Text] [Related]
20. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
